Annona muricata

Soursop (Annona muricata) contains acetogenins, bioactive compounds that demonstrate selective cytotoxicity against cancer cells by inhibiting mitochondrial complex I. These compounds show particular promise in preclinical studies for colorectal and breast cancer applications.

Origin & History

Annona muricata, commonly known as graviola or soursop, is a tropical evergreen tree native to the Americas, particularly the Caribbean and Central/South America, now cultivated widely in tropical regions globally. The plant's leaves, fruit, and pericarp are primary sources for medicinal extracts, typically prepared as aqueous infusions, methanol, or DMSO extracts from leaves.

Historical & Cultural Context

Annona muricata has been used in Caribbean, South American, and African traditional medicine for centuries to treat cancer, diabetes, infections, and inflammation. In modern Jamaican and Trinidad oncology clinics, 60-80.9% of cancer patients self-medicate with it, demonstrating persistent traditional use.

Health Benefits

• Colorectal cancer support: In a randomized controlled trial (n=28), leaf extract showed higher ex vivo serum cytotoxicity against colorectal cancer cell lines after 8 weeks (moderate evidence, PMID: 28582808)
• Potential anti-cancer activity: Preclinical studies demonstrate cytotoxicity against breast, colon, lung, and prostate cancer cell lines with ED50 values <1 µg/mL (preliminary evidence)
• Synergistic effects with chemotherapy: In vitro studies show enhanced anticancer effects when combined with cisplatin in breast cancer cells (preliminary evidence)
• Low toxicity to healthy cells: IC50 >962 µg/mL in normal endothelial and fibrosarcoma cells suggests selective cytotoxicity (preliminary evidence)
• Traditional diabetes management: Historical use for diabetes treatment, though clinical evidence is lacking (traditional evidence only)

How It Works

Soursop's primary bioactive compounds, annonaceous acetogenins including annonacin and muricin, selectively inhibit mitochondrial NADH-ubiquinone oxidoreductase (complex I) in cancer cells. This disruption of cellular respiration leads to ATP depletion and subsequent apoptosis in malignant cells while sparing healthy tissue. The acetogenins also modulate reactive oxygen species production and may influence p53-mediated cell cycle arrest pathways.

Scientific Research

Human clinical evidence is extremely limited, with only one identified randomized controlled trial (PMID: 28582808) testing daily oral A. muricata leaf extract in 28 colorectal cancer patients for 8 weeks. No meta-analyses or additional RCTs were identified, with most evidence coming from preclinical in vitro studies using cancer cell lines at concentrations of 125-250 µg/mL.

Clinical Summary

A randomized controlled trial with 28 participants demonstrated that soursop leaf extract increased ex vivo serum cytotoxicity against colorectal cancer cell lines after 8 weeks of supplementation. Preclinical studies show cytotoxic activity against breast cancer cells, though human clinical data remains limited. The current evidence is primarily based on in vitro studies and small human trials, requiring larger clinical investigations to establish therapeutic efficacy. Most research focuses on leaf extracts rather than fruit consumption.

Nutritional Profile

Annona muricata (soursop) fruit pulp composition per 100g fresh weight: Carbohydrates 16.8g (primary macronutrient), dietary fiber 3.3g (soluble and insoluble fractions), protein 1.0g, fat 0.3g, water 81.2g, calories ~66 kcal. Key micronutrients: Vitamin C 20.6mg (23% DV), folate 14µg, thiamine (B1) 0.07mg, riboflavin (B2) 0.05mg, niacin (B3) 0.9mg, pyridoxine (B6) 0.059mg. Minerals: potassium 278mg (dominant mineral), magnesium 21mg, phosphorus 27mg, calcium 14mg, sodium 14mg, iron 0.6mg, zinc 0.1mg. Primary bioactive compounds: Acetogenins (annonaceous acetogenins) including annonacin (~0.001–15mg/100g in pulp, higher in seeds/leaves), annonacinone, bullatacin, squamocin — these are the principal cytotoxic compounds with mitochondrial complex I inhibition activity. Alkaloids: reticuline, coreximine, anomurine present predominantly in leaves and bark. Phenolic compounds: quercetin, kaempferol, isoquercitrin, chlorogenic acid (leaves contain ~18.5mg GAE/g dry weight total phenolics). Terpenes: beta-caryophyllene, p-cymene in leaf extracts. Bioavailability notes: Acetogenin bioavailability is poorly characterized in humans; lipophilic nature suggests fat-enhanced absorption. Vitamin C bioavailability is moderate (~70%) consistent with other fruit sources. Seed and leaf concentrations of acetogenins are 10–100x higher than pulp; annonacin in seeds reaches ~3.8mg/100g fresh weight. Neurotoxicity risk noted with high acetogenin exposure, particularly annonacin, linked to atypical parkinsonism in epidemiological studies from endemic regions.

Preparation & Dosage

Clinical dosages are poorly defined. The sole RCT used daily oral leaf extract for 8 weeks (specific mg not detailed). In vitro studies used 125-250 µg/mL aqueous leaf infusions and 15-240 µg/mL methanol leaf extracts. No standardization for acetogenin content has been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Green Tea Extract, Resveratrol, Vitamin D3, Milk Thistle

Safety & Interactions

Soursop may cause neurological side effects with chronic high-dose consumption due to neurotoxic acetogenins, potentially contributing to atypical parkinsonism. The supplement may interact with antihypertensive medications due to its hypotensive effects and could enhance the effects of diabetes medications. Pregnant and breastfeeding women should avoid soursop supplements due to insufficient safety data. Individuals with Parkinson's disease or movement disorders should exercise particular caution.